The candidature of the Clínic-IDIBAPS researcher was approved with 90% of the votes at the general assembly of the European Association for the Stu...
They are the Translational cancer research program, the Synaptic autoimmunity in neurology, psychiatry and cognitive neuroscience program and the L...
The IDIBAPS researcher Josep M. Llovet has participated in the new American AASLD guidelines for the treatment of hepatocellular carcinoma, the mos...
On Monday, March 13, the Spanish Association Against Cancer (AECC) announced the 2022 AECC Cancer Research Grants.
The list, published by Clarivate Analytics, identifies the most influential experts, who are among the 1% most highly cited in their speciality in...
In an important breakthrough in precision medicine and for the approval of cost-effective treatments, the expression of eleven genes is found to ma...
Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which th...
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in...
Researchers at IDIBAPS have led a study, published in the journal Gastroenterology, in which they analyzed the clinical trials published in the pas...
IDIBAPS researchers have drafted a molecular map of the most common type of liver cancer, hepatocellular carcinoma, when the origin is fatty liver...
